Savara Inc (SVRA) Form 10-Q Quarterly Reports
Savara Inc (SVRA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SVRA
CIK: 1160308
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerKristin Keating
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-25 | 2026-09-24 | 4 | 0001193125-26-403070 | View SEC Doc Filr Page |
| S-8 | 2026-08-11 | — | S-8 | 0001193125-26-344992 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344585 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-15 | 4 | 0001193125-26-316442 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-22 | 4 | 0001193125-26-278061 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0001974078-26-000253 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-04 | 8-K | 0001193125-26-261770 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219371 | View SEC Doc Filr Page |
| ARS | 2026-04-24 | 2025-12-31 | ARS | 0001193125-26-177384 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-24 | — | DEFA14A | 0001193125-26-177360 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-04 | DEF 14A | 0001193125-26-177353 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-10 | 2026-06-04 | PRE 14A | 0001193125-26-151313 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-18 | 4 | 0001193125-26-117669 | View SEC Doc Filr Page |
| 8-K | 2026-03-13 | 2026-03-10 | 8-K | 0001193125-26-105099 | View SEC Doc Filr Page |
| 10-K | 2026-03-13 | 2025-12-31 | 10-K | 0001193125-26-105076 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001738048-26-000030 | View SEC Doc Filr Page |
| 4 | 2026-02-17 | 2026-02-16 | 4 | 0001193125-26-055175 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001193125-26-054767 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001231919-26-000145 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001104659-26-015345 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-05 | — | SCHEDULE 13G/A Filing | 0000908834-26-000046 | View SEC Doc Filr Page |
| 8-K | 2026-01-27 | 2026-01-26 | 8-K | 0001193125-26-023378 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-01-21 | — | SCHEDULE 13G Filing | 0002012383-26-000788 | View SEC Doc Filr Page |
| 8-K | 2026-01-09 | 2026-01-09 | 8-K | 0001193125-26-008301 | View SEC Doc Filr Page |
| 4 | 2025-12-19 | 2025-12-19 | 4 | 0001193125-25-327035 | View SEC Doc Filr Page |